FDX1
Adrenodoxin, mitochondrial
Also known as: ADX, ADX_HUMAN, FDX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10109
- Gene
- FDX1
- Ensembl
- ENSG00000137714
- Chromosome
- 11
- Canonical length
- 184 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a small iron-sulfur protein that transfers electrons from NADPH through ferredoxin reductase to mitochondrial cytochrome P450, involved in steroid, vitamin D, and bile acid metabolism. Pseudogenes of this functional gene are found on chromosomes 20 and 21. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
184 residues, UniProt reviewed canonical sequence.
>P10109|FDX1
1 MAAAGGARLL RAASAVLGGP AGRWLHHAGS RAGSSGLLRN RGPGGSAEAS RSLSVSARAR
61 SSSEDKITVH FINRDGETLT TKGKVGDSLL DVVVENNLDI DGFGACEGTL ACSTCHLIFE
121 DHIYEKLDAI TDEENDMLDL AYGLTDRSRL GCQICLTKSM DNMTVRVPET VADARQSIDV
181 GKTSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FDX1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 300 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 300 nTPM
- liver: 41 nTPM
- kidney: 28 nTPM
- seminal vesicle: 25 nTPM
- duodenum: 21 nTPM
- skeletal muscle: 19 nTPM
Single-cell type
- adrenal cortex cells: 1,824 nCPM
- syncytiotrophoblasts: 1,367 nCPM
- mast cells: 406 nCPM
- parietal cells: 263 nCPM
- hepatocytes: 224 nCPM
- extravillous trophoblasts: 212 nCPM
Immune cell
- memory B-cell: 9.7 nTPM
- naive B-cell: 7.5 nTPM
- T-reg: 7.4 nTPM
- naive CD4 T-cell: 6.2 nTPM
- memory CD8 T-cell: 5.4 nTPM
- memory CD4 T-cell: 5.2 nTPM
Brain region
- choroid plexus: 17 nTPM
- white matter: 17 nTPM
- midbrain: 16 nTPM
- thalamus: 16 nTPM
- pons: 15 nTPM
- spinal cord: 15 nTPM
ReferencesPubMed · IEDB
Publications for FDX1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Anti-FDX1 Autoantibody as a Potential Biomarker for Non-Small Cell Lung Cancer Detection.
2025 · Cancer Epidemiol Biomarkers Prev · RCR 1.9 · 6 citations - Plasma anti-FDX1 autoantibody as a potential biomarker for detection and diagnosis of breast cancer.
2026 · Clin Immunol
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- -0.27
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to cAMP
- cellular response to forskolin
- cholesterol metabolic process
- electron transport chain
- hormone biosynthetic process
- P450-containing electron transport chain
- steroid biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FDX1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FDX1 as an antibody target. Whether an autoantibody or antibody against FDX1 could matter depends on whether native FDX1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FDX1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FDX1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...